Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1989 5
1990 5
1991 1
1992 3
1993 2
1995 1
1996 4
1997 3
1998 3
2000 1
2001 3
2002 6
2003 6
2004 9
2005 10
2006 4
2007 4
2008 10
2009 13
2010 6
2011 9
2012 17
2013 15
2014 15
2015 12
2016 12
2017 11
2018 11
2019 13
2020 12
2021 16
2022 12
2023 20
2024 16
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

272 results

Results by year

Filters applied: . Clear all
Page 1
Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial.
Carmeli Y, Cisneros JM, Paul M, Daikos GL, Wang M, Torre-Cisneros J, Singer G, Titov I, Gumenchuk I, Zhao Y, Jiménez-Rodríguez RM, Liang L, Chen G, Pyptiuk O, Aksoy F, Rogers H, Wible M, Arhin FF, Luckey A, Leaney JL, Pypstra R, Chow JW; COMBACTE-CARE consortium REVISIT study group. Carmeli Y, et al. Lancet Infect Dis. 2025 Feb;25(2):218-230. doi: 10.1016/S1473-3099(24)00499-7. Epub 2024 Oct 7. Lancet Infect Dis. 2025. PMID: 39389071 Clinical Trial.
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.
Kaasch AJ, López-Cortés LE, Rodríguez-Baño J, Cisneros JM, Dolores Navarro M, Fätkenheuer G, Jung N, Rieg S, Lepeule R, Coutte L, Bernard L, Lemaignen A, Kösters K, MacKenzie CR, Soriano A, Hagel S, Fantin B, Lafaurie M, Talarmin JP, Dinh A, Guimard T, Boutoille D, Welte T, Reuter S, Kluytmans J, Martin ML, Forestier E, Stocker H, Vitrat V, Tattevin P, Rommerskirchen A, Noret M, Adams A, Kern WV, Hellmich M, Seifert H; SABATO study group. Kaasch AJ, et al. Lancet Infect Dis. 2024 May;24(5):523-534. doi: 10.1016/S1473-3099(23)00756-9. Epub 2024 Jan 17. Lancet Infect Dis. 2024. PMID: 38244557 Clinical Trial.
Optimizing the Clinical Use of Vancomycin.
Álvarez R, López Cortés LE, Molina J, Cisneros JM, Pachón J. Álvarez R, et al. Antimicrob Agents Chemother. 2016 Apr 22;60(5):2601-9. doi: 10.1128/AAC.03147-14. Print 2016 May. Antimicrob Agents Chemother. 2016. PMID: 26856841 Free PMC article. Review.
Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial.
Molina J, Montero-Mateos E, Praena-Segovia J, León-Jiménez E, Natera C, López-Cortés LE, Valiente L, Rosso-Fernández CM, Herrero M, Aller-García AI, Cano Á, Gutiérrez-Gutiérrez B, Márquez-Gómez I, Álvarez-Marín R, Infante C, Roca C, Valiente-Méndez A, Pachón J, Reguera JM, Corzo-Delgado JE, Torre-Cisneros J, Rodríguez-Baño J, Cisneros JM; SHORTEN trial team. Molina J, et al. Clin Microbiol Infect. 2022 Apr;28(4):550-557. doi: 10.1016/j.cmi.2021.09.001. Epub 2021 Sep 9. Clin Microbiol Infect. 2022. PMID: 34508886 Free article. Clinical Trial.
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.
Aguilar-Guisado M, Espigado I, Martín-Peña A, Gudiol C, Royo-Cebrecos C, Falantes J, Vázquez-López L, Montero MI, Rosso-Fernández C, de la Luz Martino M, Parody R, González-Campos J, Garzón-López S, Calderón-Cabrera C, Barba P, Rodríguez N, Rovira M, Montero-Mateos E, Carratalá J, Pérez-Simón JA, Cisneros JM. Aguilar-Guisado M, et al. Lancet Haematol. 2017 Dec;4(12):e573-e583. doi: 10.1016/S2352-3026(17)30211-9. Epub 2017 Nov 15. Lancet Haematol. 2017. PMID: 29153975 Clinical Trial.
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study.
Kuehl R, Morata L, Boeing C, Subirana I, Seifert H, Rieg S, Kern WV, Kim HB, Kim ES, Liao CH, Tilley R, Lopez-Cortés LE, Llewelyn MJ, Fowler VG, Thwaites G, Cisneros JM, Scarborough M, Nsutebu E, Gurgui Ferrer M, Pérez JL, Barlow G, Hopkins S, Ternavasio-de la Vega HG, Török ME, Wilson P, Kaasch AJ, Soriano A; International Staphylococcus aureus collaboration study group and the ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis. Kuehl R, et al. Lancet Infect Dis. 2020 Dec;20(12):1409-1417. doi: 10.1016/S1473-3099(20)30447-3. Epub 2020 Aug 4. Lancet Infect Dis. 2020. PMID: 32763194
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study.
Cornely OA, Cisneros JM, Torre-Cisneros J, Rodríguez-Hernández MJ, Tallón-Aguilar L, Calbo E, Horcajada JP, Queckenberg C, Zettelmeyer U, Arenz D, Rosso-Fernández CM, Jiménez-Jorge S, Turner G, Raber S, O'Brien S, Luckey A; COMBACTE-CARE consortium/REJUVENATE Study Group. Cornely OA, et al. J Antimicrob Chemother. 2020 Mar 1;75(3):618-627. doi: 10.1093/jac/dkz497. J Antimicrob Chemother. 2020. PMID: 31828337 Free PMC article. Clinical Trial.
Aztreonam-avibactam for the treatment of serious infections caused by metallo-β-lactamase-producing Gram-negative pathogens: a Phase 3 randomized trial (ASSEMBLE).
Daikos GL, Cisneros JM, Carmeli Y, Wang M, Leong CL, Pontikis K, Anderzhanova A, Florescu S, Kozlov R, Rodriguez-Noriega E, Psichogiou M, Rattanaumpawan P, Streinu-Cercel A, Ramasubramanian V, Arhin FF, Rogers H, Wible M, Leaney J, Jacobson D, Pypstra R, Chow JW. Daikos GL, et al. JAC Antimicrob Resist. 2025 Jul 28;7(4):dlaf131. doi: 10.1093/jacamr/dlaf131. eCollection 2025 Aug. JAC Antimicrob Resist. 2025. PMID: 40727714 Free PMC article.
COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study.
Infante-Domínguez C, Salto-Alejandre S, Álvarez-Marín R, Sabé N, Ramos-Martínez A, Moreno A, Ferreira de Moraes K, Palacios-Baena ZR, Muñoz P, Fernández-Ruiz M, Blanes M, Fariñas C, Vidal E, Merino de Lucas E, Halpern M, Hernández-Gallego R, Bassetti M, Mularoni A, Gutiérrez-Dalmau A, Rinaldi M, Jiménez-Jorge S, Bodro M, Aranha-Camargo LF, Valerio M, Sánchez-Céspedes J, Gutiérrez-Gutiérrez B, Giannella M, Rodríguez-Baño J, Pachón J, Cordero E; COVIDSOT, ORCHESTRA Working Teams. Infante-Domínguez C, et al. Sci Rep. 2024 Dec 3;14(1):30021. doi: 10.1038/s41598-024-81099-2. Sci Rep. 2024. PMID: 39622951 Free PMC article.
Antifungal combination therapy for invasive aspergillosis.
Martín-Peña A, Aguilar-Guisado M, Espigado I, Cisneros JM. Martín-Peña A, et al. Clin Infect Dis. 2014 Nov 15;59(10):1437-45. doi: 10.1093/cid/ciu581. Epub 2014 Jul 21. Clin Infect Dis. 2014. PMID: 25048847 Review.
272 results